Abstract
Purpose of Review
This review aims to identify and characterize which neglected infections of poverty (NIPs) represent a public health risk in the United States (US) and describe the health disparities these NIPs represent within the US population. Another aim of this review is to describe public health surveillance for NIPs in the US, including potential gaps in surveillance, and suggest actions to mitigate the disparities represented by these infections.
Recent Findings
Data are insufficient to reliably estimate prevalence, burden of disease, and provide optimal diagnostics and treatment for various NIPs in the US. Some of these infections have a long history in the US; others emerged more recently and are expected to increase with climate change. Virtually all NIPs represent racial and economic disparities.
Summary
We provide an updated review of risk factors and suggest actions state, Tribal, local, and territorial public health jurisdictions can take now to respond to this uniquely American crisis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Neglected infections of poverty (NIPs) are caused by viruses, bacteria, fungi, and parasites for which United States (US) clinical and public health communities lack sufficient data to reliably estimate prevalence, burden of disease, and provide optimal diagnostic and treatment strategies [1]. NIPs disproportionately affect people living in poverty and underrepresented minority populations, tend to be concentrated in areas of high poverty, and perpetuate poverty in these areas because of their adverse impact on child development, pregnancy, and worker productivity [2]. Some of these infections have a long history in the US; others emerged more recently and are expected to increase with climate change. While the risks are unique for each due to different ecological, epidemiologic, and biological factors, virtually, all NIPs represent racial and economic disparities owing to risk factors common among low-income populations: substandard housing, occupational hazards, limited access to health care and public health services, and poorer nutrition and immunocompetence. According to the US Census Bureau, 2021 child poverty rates are highest among Hispanic (8.4%), Black (8.1%), and Asian (5.1%) children and lowest among non-Hispanic white (2.7%) children [3].
Collectively, the impact of NIPs on US population health is mediated through maternal, neonatal, and child morbidity and mortality; impairment of physical and cognitive development; decreased socioeconomic productivity and quality of life; and higher risks of severe disease and death for elder and immunocompromised populations [4,5,6,7, 8••, 9,10,11,12].
The aim of this review is to identify and characterize which NIPs represent a public health risk in the US and describe the health disparities these NIPs pose within the US population. Another aim of this review is to describe public health surveillance for NIPs in the US, including gaps, and suggest actions to mitigate the disparities represented by these infections.
Methods
This study followed PRISMA guidelines for systematic reviews [13]. We conducted a literature search in April 2023 of five databases—Cochrane, Google Scholar, Scopus, Web of Science, and PubMed—using search terms focused on health disparities in tropical diseases in the US and a 10-year publication limit. Full details of search syntax per database are available upon request. One reviewer screened each record and conferred with a second reviewer if it was unclear whether inclusion criteria were satisfied. Articles met inclusion criteria if they (1) included US data or case reports, (2) focused on human cases or risk to human health, (3) described an NIP or group of NIPs, and (4) were peer-reviewed. Opinion-based articles, in vitro studies, and bibliometric analyses were excluded from this review. References of included articles were hand-searched, and additional relevant studies that met inclusion criteria were included.
Each included article was reviewed by one or both reviewers and summarized using a standardized article extraction form. This form collected descriptive information including the setting and population, the infection(s), bias or limitations, study design, outcome or hypothesis, and results of each study. Zotero (Corporation for Digital Scholarship) was used to manage references.
Results/Findings
Our search of Cochrane, Google Scholar, Scopus, Web of Science, and PubMed yielded 0, 53, 65, 67, and 32 results, respectively, with 47 duplicates. A total of 155 articles were identified that met our inclusion criteria; 111 (72%) of these were identified by hand-searching references. The full reference list is available upon request. Further details of our search process are described in Fig. 1.
Our findings suggest that a diverse group of NIPs impact US population health and pose disparities, often along racial, geographic, and socioeconomic lines. Vector-borne infections in the US include arboviruses, Chagas disease, and leishmaniasis; exposure to insect vectors is a proxy for poverty. The sexually transmitted infection trichomoniasis represents a stark health disparity for US Black women. A wide array of helminth infections, including several zoonoses, threaten US public health and disproportionately affect poor minority populations. The individual NIPs, their reported geographic ranges, populations most at risk, and national notifiability status are summarized in Table 1.
Arboviruses
Chikungunya
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus spread by Aedes spp. mosquitoes. Rheumatologic disease is a notable clinical feature of this virus and can be severe, particularly in older adults [33]. Most cases of CHIKV in the US occur among persons who have traveled to endemic areas or areas with current virus activity. However, the vectors are found in the US and infected, returning travelers provide an opportunity for virus introduction. This is evident through local transmission events that have occurred sporadically in limited geographic areas of the US, with the first occurrence of local transmission occurring in South Florida in 2014 [34].
Zika Virus
Zika virus is a flavivirus that presents unique prevention and control challenges as it is transmitted by Aedes spp. mosquitoes as well as through congenital and sexual transmission. Although most Zika infections result in asymptomatic or mild illness, fetal microcephaly and pregnancy loss can occur in patients who become infected while pregnant [35, 36]. In March 2015, the first cases of Zika virus were identified in the Americas in Brazil; by March 2016, Zika had spread to over 30 other countries and territories in the Americas [5]. Zika rapidly spread throughout Puerto Rico resulting in hundreds of cases [37,38,39]. Zika virus cases also increased in the contiguous US during this time primarily due to travel-related exposures [40] prompting public health officials to recommend pregnant women consider postponing travel to areas with Zika activity. Zika testing guidance was also released to health care providers including the recommendation to test asymptomatic pregnant patients with possible exposure to Zika [41]. Also, in 2016, the first sexually transmitted cases were reported [42, 43], and local transmission in the contiguous US was first identified in Florida [44].
Dengue
Dengue is a mosquito-borne illness caused by one of four related viruses and spread by Aedes spp. mosquitoes. Dengue is not endemic in the US, but sporadic, local outbreaks have occurred in Hawaii, Texas, and Florida [45, 46] and travel-related cases have occurred along the US-Mexico border including during a dengue outbreak in northern Mexico [47].
As the mosquito vector is the same for CHIKV, dengue, and Zika virus, areas where this vector is sustained in the US are at highest risk for introduction from infected travelers and local transmission. These areas primarily include southern Florida, Texas, and Hawaii. In the US territories, no cases of Zika or CHIKV have been identified since 2019; however, dengue cases are common. Clustering of cases within households has been demonstrated in previous outbreaks [46, 48]. Preventing mosquito bites and removing mosquito breeding sites are essential to limiting transmission. Contact with mosquitoes is increased for populations living in substandard housing lacking air conditioning and screens and urbanized, overcrowded areas, where breeding sites can be abundant [5, 49, 50].
Chagas Disease
Chagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi and is transmitted to animals and people via the triatomine insect vector. While endemic in parts of Latin America, autochthonous CD cases have also been reported in the US [15, 35, 36, 51•, 52, 53] and there is concern that CD could become more prevalent due to expansion of the vector’s range from climate change and human encroachment upon the vector’s habitat [54•]. Transmission through blood transfusions and organ transplantation as well as congenital transmission prompted efforts to screen blood donors in the US for CD [55] and advocate for CD screening in women of reproductive age [54•]. Dilated cardiomyopathy is an important and costly clinical feature that often goes undiagnosed as CD and can lead to poor long-term outcomes, including unexpected death [56].
Immigrants to the US from endemic areas of Latin America are at highest risk for infection and can face barriers to appropriate care once in the US [57•]. The disease burden of CD in the US has been estimated at approximately 238,091 cases to over 300,000 cases with California, Texas, Florida, and New York having the highest number of cases due to immigrant populations in these states [6, 58]. Substandard housing is a risk for exposure to the vector. Outdoor activity and exposure to other animals might also increase the risk of CD exposure [59]. Seroprevalence studies in dogs from Texas where the vector is widespread suggest increased risk for human exposure to T. cruzi [60].
Chromoblastomycosis, Mycetoma, and Nocardiosis
Mycetoma is a chronic, destructive bacterial or fungal infection of the skin and subcutaneous tissue and can lead to significant disability and mortality [61]. Poverty and rural residence are risk factors but there are no prevalence data for the US [62]. The disease is most rigorously studied and reported from Mexico, India, and Sudan; emergence of new geographical loci includes the US and the Americas, where bacterial forms appear to dominate [61]. Cases of nocardial mycetoma and nocardiosis (caused by bacteria in the Nocardia genus) have been reported from eastern Virginia [29], Massachusetts [30], Texas [31], and Florida [32]; 500–1,000 cases are reported annually in the US [63], with most but not all associated with preexisting immunocompromising conditions [64]. The clinical spectrum of nocardiosis ranges from localized skin and soft tissue infections to life-threatening pulmonary, CNS, and/or disseminated infections [32]. Antibiotic resistance in Nocardia spp. isolates from the US has been reported and is highly variable by agent and by species [31, 63, 64].
Chromoblastomycosis (CBM) is a fungal infection most diagnosed in impoverished and marginalized people who live in remote and rural areas [65]. Between 1915 and 2018, 24 US cases were reported, most around the 1950s and most occurring in the south or southeast, with some limited cases in the northeast [28, 65]. Risk factors include traumatic injuries with soil contamination, agricultural activities, landscaping, and post-hurricane settings [28, 66]. CBM and mycetoma are considered occupational diseases associated with social stigma and severe socioeconomic consequences [61, 65].
Helminths
Ascariasis
Ascaris spp. are parasitic nematodes that can cause infection in humans and pigs [18]. A. lumbricoides is generally thought of as a human parasite and A. suum as a pig parasite, though they can cross-infect and there is debate as to whether they are the same species [67]. Ascariasis persists in commercial swine in the US posing a risk of zoonotic transmission [67]. Infection with Ascaris spp., ascariasis, is not nationally notifiable and is to our knowledge only reportable in Texas (as of 2016); the same is true for hookworm (below). Fourteen cases of ascariasis were identified in persons who had contact with pigs in Maine during 2010–2013 [18]. An 8-year-old child was diagnosed with ascariasis complicated by Löffler syndrome, a pneumonitis resulting from migration of Ascaris larvae through the lungs, after contact with pigs on a southern Louisiana farm [19]. While recently reported cases are zoonotic, Ascaris is predominantly a soil-transmitted helminth (STH) that causes infection when eggs from other infected humans are ingested. However, the current prevalence of soil-transmitted ascariasis in the US is unknown.
Hookworm
Another STH, human hookworm infection caused by Necator americanus was prevalent in about 40% of the US south population when the Rockefeller Sanitary Commission for the Eradication of Hookworm Disease (1909–1914) fielded its philanthropic public health project across 11 states: Virginia, North Carolina, Georgia, South Carolina, Tennessee, Arkansas, Mississippi, Alabama, Louisiana, Kentucky, and Texas [20]. Between 2010 and 2013, 100 hookworm infections were identified in newly resettled refugees in Texas and conferred a significantly increased odds of latent tuberculosis infection [68]. Poor, Black residents of Lowndes County, Alabama without a travel history recently tested positive for N. americanus by stool, highlighting the persistence of the parasite in areas of high poverty in the US [10].
Strongyloidiasis
Strongyloides stercoralis is another STH, though, like hookworm, is predominantly transmitted via skin penetration by infective larvae. S. stercoralis is the most neglected of the STH; the diagnostic methods used in historical STH surveys were insensitive to this species and it was often excluded or underestimated [17]. S. stercoralis is also unique among STH in its ability to persist and replicate in the human host lifelong, during which the infection is asymptomatic unless and until the host becomes immunocompromised; in that event, the infection becomes acutely life-threatening by dissemination and hyperinfection [9, 21]. These complications of latent strongyloidiasis have a high mortality rate approaching 90%; complicated strongyloidiasis is preventable and often due to negligence, lack of awareness, and failure by health care providers to recognize the need for parasite screening before prescribing corticosteroids [8••, 21, 23••]. Disseminated strongyloidiasis is relatively common in populations at high risk for infection and is often misdiagnosed as gram-negative septicemia or acute respiratory distress syndrome [21]. Deaths from strongyloidiasis have been reported in a majority of states, with most deaths among persons born in the US [69].
A recent study by one of the authors detected 16.5% seroprevalence in a sample of predominantly poor Mexican American central Texas residents, many of whom had not traveled [23••]. Others found 7.3% of stool samples positive for S. stercoralis from a sample of poor Black residents in rural Alabama [10]. While the extent of autochthonous transmission is unknown, strongyloidiasis also represents a significant health threat among immigrant populations in the US, albeit underrecognized [70•]. Strongyloidiasis was among the most common infections identified in a review of a decade of outpatient tropical medicine in Houston, TX [71]. There is recent evidence of ongoing transmission in rural Kentucky [24]. The author’s modeling study predicts suitable habitat for S. stercoralis in at least ten states beyond the southeastern US where it has been recorded; based on climate and poverty data, the likely distribution of the parasite includes states in the south, east and northeast, and west coasts [22•]. We recommend strongyloidiasis should be reportable in at least the states with historical and predicted endemic risk. Strongyloidiasis is not nationally notifiable nor is it currently reportable in any state; however, the Council of State and Territorial Epidemiologists voted to establish a standardized surveillance case definition for strongyloidiasis in 2022 [72].
Toxocariasis
Toxocara spp. are roundworms of cats, dogs, and other domestic and wild animals; humans become infected when they accidentally ingest eggs which animal hosts excrete into the human environment at high rates [73]. Like other NIPs, this common zoonosis exhibits striking disparities in prevalence across races, with reported seroprevalence in the US Black population of 21.2% compared to 12% in the US white population [12]. In a study of US-born New York City (NYC) residents, overall seroprevalence was 8.5% with wide variation by borough, with the lowest (3.5%) in Manhattan. Mexican Americans had the highest seroprevalence (32.2%), over three times that of African Americans (10.4%) and over five times that of whites (7.5%) and individuals of undefined ethnicity (7.4%). The same study demonstrated significantly diminished lung function in seropositive participants, which further supports associations between toxocariasis and asthma [25]. Another study detected the highest contamination of playgrounds by Toxocara eggs in the Bronx, which has the lowest median income of all NYC boroughs and the lowest contamination rate in Manhattan, which has the highest median income [74••].
Toxocariasis, which clinically manifests as covert [11], ocular (OT, which can lead to blindness), or visceral toxocariasis (VT, which can be fatal), primarily impacts children because of their play habits and poor hygiene and is found disproportionately among Black children [12]. Toxocariasis is also associated with cognitive dysfunction in adults [75]. Like other NIPs, toxocariasis is completely preventable, can be devasting, and is not under surveillance in the US. Toxocariasis exemplifies the critical need for a One Health approach to prevention and control, involving a closer collaboration between veterinary and public health professionals and an integrated lens to public health [73, 76, 77].
Taeniasis and Cysticercosis
Taeniasis is a patent tapeworm infection occurring when humans ingest cysticeri from a pig. Cysticercosis occurs only after ingestion of eggs from a person with taeniasis, making taeniasis the source of autochthonous transmission of cysticercosis. The complete transmission cycle can be maintained in focal areas of the US. Despite its relevance to cysticercosis, there are few prevalence data on taeniasis [7]. Cysticercosis is underreported even in jurisdictions where it is reportable; very few surveillance programs have been implemented [78]. Up to 2% of US emergency department visits for seizures are caused by cysticercosis; the infection is increasingly recognized as a cause of severe and preventable neurologic disease in the US [7]. Studies of disease burden in Oregon and California found higher incidence in people who identified as Hispanic and that 5.4–18% of hospitalized patients were US-born [7].
Symptomatic human cysticercosis almost invariably presents as neurocysticercosis; this form of the disease consumes significant health resources and causes significant mortality, disproportionately among the Hispanic (particularly males aged 20–44) population, for which the risk for hospitalization has been estimated at 35 times that of the white population [7, 78, 79]. All regions of the US are impacted by cysticercosis-related hospitalizations; some argue that cysticercosis should be nationally notifiable [78].
Schistosomiasis
Schistosomiasis, infection with blood flukes, is dependent on exposure to freshwater containing snails that maintain the parasite’s life cycle; transmission does not occur in the US. The infection enters the US through immigration and travel. Tourists often present with severe acute disease that many US clinicians are not trained to diagnose [80]. Of the more than 8,000 people estimated to be living in the US with schistosomiasis, most are African refugees [71]. Routine screening of all at-risk individuals is necessary to prevent morbidity from complications of chronic schistosomiasis, such as bladder cancer and pulmonary hypertension [71].
Leishmaniasis
Leishmaniasis is a protozoan zoonosis transmitted by the bite of the Lutzomyia sandfly. More than 24 different Leishmania species cause three main clinical subtypes: visceral, cutaneous (CLM), and mucocutaneous [81]. CLM is a disfiguring disease process, and there is no FDA-approved drug to treat it in the US [82]. Leishmaniasis is typically limited to foreign travelers, immigrants, and military personnel in the US; however, L. mexicana is endemic to Texas with a known mammalian reservoir, the Texas wood rat. The habitat of the Texas wood rat has shifted toward northeast Texas and southeast Oklahoma; a recent case series reported 9 locally transmitted cases of CLM in north Texas around Dallas-Fort Worth [82, 83]. A total of 33 autochthonous cases of CLM have been reported in the US, mostly in south central Texas, including two from southeastern Oklahoma as well as one case of a 2-year-old child with no travel history in Houston [82, 83].
Findings of sandfly surveys establish the presence of suitable Lutzomyia spp. vectors in the vicinity of Texas and Oklahoma cases, though trapping yield was low [83]. Sandfly control is extremely difficult because they travel considerable distances from breeding areas to feed [84]. There is an apparent trend of diagnosing human CLM with increasing frequency in the US as well as increasingly northeastward; 13 cases were reported from 2000–2007, whereas 29 cases (primarily in south central Texas) had been reported between 1903 and 1996 [83]. Risk factors in US cases include domestic fowl, rabbits, and debris harborage to rodents around residence [83]. Ecological niche modeling predicts that the range of the sandfly vector and rodent reservoir of L. mexicana will continue a northward expansion spurred by climate change [83].
One study explored trends and risk factors for leishmaniasis among hospitalized women of reproductive age in the US, finding an overall low prevalence of 1.57 cases per million during 2002–2017 and highest risk among women who were 35–49 years old, Hispanic, on Medicare, and who were inpatients at a large teaching hospital in the northeast [81]. A cross-sectional multicenter observational study of US cases from 2007 through 2017 identified 69 CLM cases, 41 (59%) of which were endemic [85]. These findings suggest that CLM is more frequently acquired endemically than via travel; the authors argue that leishmaniasis should be nationally notifiable, especially considering that climate models predict the number of US residents exposed to L. mexicana will double by 2080 [85].
Trichomoniasis
Infection with the protozoan parasite Trichomonas vaginalis (TV) is common, preventable, curable, and associated with significant reproductive and perinatal morbidity as well as increased risk of HIV acquisition and transmission [86, 87, 88••, 89]. TV is the most prevalent non-viral sexually transmitted infection in the US and likely globally yet has received much less consideration than other parasitic and sexually transmitted infections; this neglect is largely attributable to a poor understanding of the public health impact of trichomoniasis and its frequently asymptomatic presentation [4, 90, 91]. The prevalence of TV in the 2013–2014 non-institutionalized US population, ages 18–59, was 0.5% in a sample of 1,942 men and 1.8% in a sample of 2,115 women [87, 88••]. Among the same population aged 14–59 years in 2013–2016, TV prevalence was 2.1% among females, 0.5% among males, and highest at 9.6% among non-Hispanic Black females [92]. Another study found 11.3% prevalence among 77,740 women and 6.1% prevalence among 12,604 men in Alabama [93]. The number of estimated incident and prevalent TV infections among 15–59-year-olds in 2018 was 6.9 million and 2.6 million, respectively; although estimated prevalence is higher among women, estimated incidence is similar in men and women [91].
Risk factors for TV identified in US populations include female sex [87, 88••, 91, 93] increased age, particularly 45 years of age and older [4, 87, 89, 90, 93, 94•]; non-Hispanic Black race/ethnicity [87, 88••, 93]; poverty below the federal poverty level [87, 88••]; and active smoking [88••]. Additional risk factors include incarceration, intravenous drug use, commercial sex work, and the presence of bacterial vaginosis [90]. One cross-sectional study assessed the relationship between drug use in the past 6 months, sexual risk behaviors, and TV infection in a sample of majority Black and female adults aged 18–64 in Baltimore, Maryland and hypothesized that age- and drug-related immune decline may contribute to increased susceptibility for TV in adults aged 45 years and older [95].
Trichomoniasis is not reportable in any state nor is it nationally notifiable; the true incidence of infection is not well established but an estimated 1.1–6.9 million persons become infected annually [4, 91]. TV is linked to an estimated 2–6% of new HIV infections annually among US women [4]. Among adults aged 18–39 years, a significant racial disparity was observed in Chlamydia trachomatis infection, genital human papillomavirus infection, herpes simplex virus type 2 serostatus, and TV infection, for which the disparity was greatest [87]. Among US women, TV infection is most prevalent among Black women with rates ranging from 13–51%, ten times higher than among white women [90]. While rates of TV infection in US males are lower than in females, TV is also fairly prevalent among men, particularly Black men, and it is important to also screen and treat men for infection [96, 97]. TV infection can also increase risk of cervical and prostate cancers [94•]. The burden of TV infection in the US adult Black population is high, disproportionate, and warrants a proportionate public health response focused on eliminating this health disparity [87].
Conclusions
Of all US residents, the poorest populations living in the US south are most impacted by parasitic infections [82]. Low-income, most often minority populations, are most susceptible to vector-borne NIPs (leishmaniasis, Chagas disease, and arboviruses) due to substandard housing lacking window screens and/or air conditioning, homelessness, and outdoor occupational risks. Travelers and immigrants are at risk of acquiring infections in endemic areas, but the risk of transmission within the US is substantial for all but schistosomiasis.
The findings of this review are subject to limitations. First, the number of articles identified by searching references far exceeded the number of articles identified on initial search of databases. This is likely because our search terms did not include names of infections or species; however, this decision was intentional to preclude biasing which infections would be characterized as neglected in the US context. Yet, the lack of coverage of infections generally thought of as neglected and disparities affecting US public health (e.g., trichuriasis, the other common STH; echinococcosis among Native American populations; and toxoplasmosis, for which the highest seroprevalence in the US is among Black people [82]) may indicate a lack of sensitivity in our search strategy.
Second, estimates of disease burden in the US population have limited reliability. Precise data on true prevalence and incidence of most of the NIPs in the US are limited, partly driven by inadequate funding to the CDC and state and local health agencies to conduct active surveillance studies [82]. The NIPs thrive in six recognized focal points of US poverty: Appalachia, Native American tribal lands, northeastern inner cities, the southern cotton belt, the Mississippi Delta, and the borderland with Mexico [84]. Prevalence estimates are generally considered to be underestimated due to potential underreporting from a lack of clinical awareness and suspicion, inadequate or nonexistent surveillance programs, and limited access to health care for vulnerable populations [4, 7, 9, 16, 23••, 33, 39, 46, 54•, 70•, 77, 81, 87, 94•, 98,99,100,101,102,103,104, 105•].
Of all the NIPs identified in this review, only infections with arboviruses are notifiable at the national level, meaning that public health jurisdictions may voluntarily report cases to the CDC (Table 1). A motif among articles reviewed is the lack of sufficient data to estimate prevalence, incidence, and disease burden and to identify risk factors with high certainty; yet, there is consensus among authors that these are important public health problems meriting those answers. In reference to the myriad gaps in our understanding of the epidemiology of cysticercosis in the US, yet applicable to all NIPs, Cantey et al. opine that these data must be complete and improved; “otherwise, we will continue to be dependent on data collected in the few areas of the country that have taken an active interest in this parasitic infection of neglected people [7].”
Ultimately, the NIPs and the conditions that promote them stem from a lack of prioritization by US policymakers; yet, control of NIPs is both a highly cost-effective mechanism for helping to address poverty and consistent with the American values of equity and equality [2]. US public health and clinical institutions also have a role to play in implementing surveillance, prevention, and control measures for these diverse infections. The neglect for these infections by public policy makers, public health, and health care institutions in the US context represents neglect of poor people living in the US.
We suggest, as have others, that educating US frontline health care providers on NIPs should be prioritized. Tropical medicine curricula should be standard, not merely elective, in US undergraduate medical education. Significant investment would be required and is warranted to expand access to tropical medicine clinics in high-prevalence areas (Gulf Coast, Appalachia, and urban areas of poverty) and to develop and implement comprehensive, systematic national screening and surveillance [71]. As a framework for national screening and surveillance, public health leaders should leverage existing health data exchange systems (e.g., electronic health records) to promote interoperability and national coverage. An integrated, multidisciplinary approach is required to address outstanding gaps in knowledge about basic NIP epidemiology, prevention, and control. For this reason, adopting a One Health approach as well as leveraging partnerships with researchers and public health practitioners is critical to embracing the complex socioeconomic and disease ecology factors at root of these disparities.
In the absence of and as a prerequisite to a coordinated national response, there are actions state, Tribal, local, and territorial (STLT) health agencies can take now to respond to this crisis of public health disparity and injustice:
-
1)
Adapt and employ surveys like the Community Assessment for Public Health Emergency Response (CASPER) [106] to characterize local risk for NIPs and make a plan for addressing findings. While the CASPER method was developed in the context of emergency response, surveys in this vein can be adapted for implementation as a risk factors assessment for individual NIPs or groups of NIPs within a jurisdiction. Data from CASPERs could then be analyzed together with public health surveillance and vector monitoring to assess the prevalence of risk factors for NIPs, guiding public health priority setting and strategy [106]
-
2)
Consider whether to conduct surveillance for any NIPs and whether they should be reportable in your jurisdiction and to which public health partners those data should be disseminated, including CDC. Individual jurisdictions can decide to mandate reporting for a condition irrespective of national policy; the Council of State and Territorial Epidemiologists in partnership with the CDC annually revises standardized surveillance case definitions and the list of nationally notifiable conditions, which provide streamlined guidance for adoption by STLT agencies
-
3)
Identify communities with substandard housing and failing sanitation and work with community members and local, state, and federal granting agencies to sustainably address those environmental hazards
-
4)
Seek and share best practices from experienced partners, including international, and adopt and advocate a human rights policy framework to eliminate the root causes of NIPs
The paradox of poverty and NIPs amidst great wealth and ingenuity can be overcome when policymakers at every level prioritize the health and rights of all Americans.
Data availability
Full results of systematic search are available upon request.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Hotez P, Stillwaggon E, McDonald M, Todman L, DiGrazia L. National summit on neglected infections of poverty in the United States. Emerg Infect Dis. 2010;16: e1.
Hotez PJ. Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis. 2008;2: e256.
U.S. Census Bureau. Figure 8. Child supplemental poverty rates by race and Hispanic origin: 2009 to 2021. Curr Popul Surv [Internet]. 2022 [cited 2023 Jun 5]; Available from: https://www.census.gov/content/dam/Census/library/visualizations/2022/demo/p60-277/figure8.pdf
Secor WE, Meites E, Starr MC, Workowski KA. Neglected parasitic infections in the United States: Trichomoniasis. Am J Trop Med Hyg. 2014;90:800–4.
Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. N Engl J Med. 2016;374:1552–63.
Montgomery SP, Starr MC, Cantey PT, Edwards MS, Meymandi SK. Neglected parasitic infections in the United States: Chagas disease. Am J Trop Med Hyg. 2014;90:814–8.
Cantey PT, Coyle CM, Sorvillo FJ, Wilkins PP, Starr MC, Nash TE. Neglected parasitic infections in the United States: Cysticercosis. Am J Trop Med Hyg. 2014;90:805–9.
•• Lier AJ, Tuan JJ, Davis MW, Paulson N, McManus D, Campbell S, et al. Case report: Disseminated strongyloidiasis in a patient with COVID-19. Am J Trop Med Hyg. 2020;103:1590–2. This case report highlights the danger of prescribing immunosuppressive therapy, including for COVID-19, prior to screening at-risk patients for Strongyloides infection. Clinicians must first be able to identify high-risk patients; this requires heightened awareness of strongyloidiasis amongst US frontline clinicians.
Page W, Judd JA, Bradbury RS. The unique life cycle of Strongyloides stercoralis and implications for public health action. Trop Med Infect Dis. 2018;3:53.
McKenna ML, McAtee S, Bryan PE, Jeun R, Ward T, Kraus J, et al. Human intestinal parasite burden and poor sanitation in rural Alabama. Am J Trop Med Hyg. 2017;97:1623–8.
Lee RM, Moore LB, Bottazzi ME, Hotez PJ. Toxocariasis in North America: A systematic review. PLoS Negl Trop Dis. 2014;8: e3116.
Woodhall DM, Eberhard ML, Parise ME. Neglected parasitic infections in the United States: Toxocariasis. Am J Trop Med Hyg. 2014;90:810–3.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.
Klotz SA, Dorn PL, Mosbacher M, Schmidt JO. Kissing bugs in the United States: Risk for vector-borne disease in humans. Environ Health Insights. 2014;8:49–59.
Hernandez S, Flores CA, Viana GM, Sanchez DR, Traina MI, Meymandi SK. Autochthonous transmission of Trypanosoma cruzi in Southern California. Open Forum Infect Dis. 2016;3:ofw227.
Waleckx E, Suarez J, Richards B, Dorn PL. Triatoma sanguisuga blood meals and potential for Chagas disease, Louisiana, USA. Emerg Infect Dis. 2014;20:2141–3.
Starr MC, Montgomery SP. Soil-transmitted helminthiasis in the United States: A systematic review–1940-2010. Am J Trop Med Hyg. 2011;85:680–4.
Miller LA, Colby K, Manning SE, Hoenig D, McEvoy E, Montgomery S, et al. Ascariasis in humans and pigs on small-scale farms, Maine, USA, 2010–2013. Emerg Infect Dis. 2015;21:332–4.
Gipson K, Avery R, Shah H, Pepiak D, Bégué RE, Malone J, et al. Löffler syndrome on a Louisiana pig farm. Respir Med Case Rep. 2016;19:128–31.
Elman C, McGuire RA, Wittman B. Extending public health: The Rockefeller Sanitary Commission and hookworm in the American South. Am J Public Health. 2014;104:47–58.
Puthiyakunnon S, Boddu S, Li Y, Zhou X, Wang C, Li J, et al. Strongyloidiasis-An insight into its global prevalence and management. PLoS Negl Trop Dis. 2014;8: e3018.
• Singer R, Sarkar S. Modeling strongyloidiasis risk in the United States. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020;100:366–72. This modeling study predicts suitable habitat for S. stercoralis in ten states beyond the southeastern US where the parasite has been reported, expanding the theoretical risk of this STH into large swaths of the country where clinicians are unaware of its potential to cause fatal disease. The study provides evidence to support the recommendation that 16 states in the ecological range of the parasite should conduct surveillance for it and promote education of clinicians so that suspicion for this infection can be appropriately applied to at-risk patients.
•• Singer R, Xu TH, Herrera LNS, Villar MJ, Faust KM, Hotez PJ, et al. Prevalence of intestinal parasites in a low-income Texas community. Am J Trop Med Hyg. 2020;102:1386–95. This study documents 16.5% seropositivity for S. stercoralis and 62.8% stool positivity for Blastocystis spp. in a central Texas community with sanitation failure.
Russell ES, Gray EB, Marshall RE, Davis S, Beaudoin A, Handali S, et al. Prevalence of Strongyloides stercoralis antibodies among a rural Appalachian population–Kentucky, 2013. Am J Trop Med Hyg. 2014;91:1000–1.
Walsh MG, Haseeb MA. Toxocariasis and lung function: Relevance of a neglected infection in an urban landscape. Acta Parasitol. 2014;59:126–31.
Ranasuriya G, Mian A, Boujaoude Z, Tsigrelis C. Pulmonary toxocariasis: A case report and literature review. Infection. 2014;42:575–8.
Boye B, Wayne M, Sukumaran S, Vijayan V. Blurry vision and irregularly shaped pupil in a 3-year-old female. Clin Pediatr (Phila). 2019;58:1038–41.
Franco-Paredes C, Mathur S, Villamil-Gomez W, Henao-Martínez AF. A man who harvest peanuts with verrucous lesions in his right index finger. Am J Med Sci. 2018;355: e7.
Palmieri JR, Santo A, Johnson SE. Soil-acquired cutaneous nocardiosis on the forearm of a healthy male contracted in a swamp in rural eastern Virginia. Int Med Case Rep J. 2014;7:41–7.
Anagnostou T, Arvanitis M, Kourkoumpetis TK, Desalermos A, Carneiro HA, Mylonakis E. Nocardiosis of the central nervous system. Medicine (Baltimore). 2014;93:19–32.
Wang H-L, Seo Y-H, LaSala PR, Tarrand JJ, Han XY. Nocardiosis in 132 patients with cancer: Microbiological and clinical analyses. Am J Clin Pathol. 2014;142:513–23.
Shannon K, Pasikhova Y, Ibekweh Q, Ludlow S, Baluch A. Nocardiosis following hematopoietic stem cell transplantation. Transpl Infect Dis Off J Transplant Soc. 2016;18:169–75.
Lang PO, Loulergue P, Aspinall R. Chikungunya virus infection: Why should US geriatricians be aware of it? J Am Geriatr Soc. 2017;65:2529–34.
Kendrick K, Stanek D, Blackmore C, Centers for Disease Control and Prevention (CDC). Notes from the field: Transmission of chikungunya virus in the continental United States-Florida, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:1137.
Meaney-Delman D, Hills SL, Williams C, Galang RR, Iyengar P, Hennenfent AK, et al. Zika virus infection among U.S. pregnant travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep. 2016;65:211–4.
Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects — Reviewing the evidence for causality. N Engl J Med. 2016;374:1981–7.
Adams L, Bello-Pagan M, Lozier M, Ryff KR, Espinet C, Torres J, et al. Update: Ongoing Zika virus transmission - Puerto Rico, November 1, 2015-July 7, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:774–9.
Dirlikov E, Ryff KR, Torres-Aponte J, Thomas DL, Perez-Padilla J, Munoz-Jordan J, et al. Update: Ongoing Zika virus transmission - Puerto Rico, November 1, 2015-April 14, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:451–5.
Thomas DL, Sharp TM, Torres J, Armstrong PA, Munoz-Jordan J, Ryff KR, et al. Local transmission of Zika virus–Puerto Rico, November 23, 2015-January 28, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:154–8.
Armstrong P, Hennessey M, Adams M, Cherry C, Chiu S, Harrist A, et al. Travel-associated Zika virus disease cases among U.S. residents–United States, January 2015-February 2016. MMWR Morb Mortal Wkly Rep. 2016;65:286–9.
Dasgupta S, Reagan-Steiner S, Goodenough D, Russell K, Tanner M, Lewis L, et al. Patterns in Zika virus testing and infection, by report of symptoms and pregnancy status - United States, January 3-March 5, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:395–9.
Chang C, Ortiz K, Ansari A, Gershwin ME. The Zika outbreak of the 21st century. J Autoimmun. 2016;68:1–13.
Hills SL, Russell K, Hennessey M, Williams C, Oster AM, Fischer M, et al. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission - Continental United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:215–6.
Likos A, Griffin I, Bingham AM, Stanek D, Fischer M, White S, et al. Local mosquito-borne transmission of Zika virus - Miami-Dade and Broward Counties, Florida, June-August 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1032–8.
Johnston D, Viray M, Ushiroda J, Whelen AC, Sciulli R, Gose R, et al. Notes from the field: Outbreak of locally acquired cases of dengue fever–Hawaii, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:34–5.
Thomas DL, Santiago GA, Abeyta R, Hinojosa S, Torres-Velasquez B, Adam JK, et al. Reemergence of dengue in southern Texas, 2013. Emerg Infect Dis. 2016;22:1002–7.
Jones JM, Lopez B, Adams L, Gálvez FJN, Núñez AS, Santillán NAH, et al. Binational dengue outbreak along the United States-Mexico border - Yuma County, Arizona, and Sonora, Mexico, 2014. MMWR Morb Mortal Wkly Rep. 2016;65:495–9.
Sharp TM, Roth NM, Torres J, Ryff KR, Pérez Rodríguez NM, Mercado C, et al. Chikungunya cases identified through passive surveillance and household investigations–Puerto Rico, May 5-August 12, 2014. MMWR Morb Mortal Wkly Rep. 2014;63:1121–8.
Dirrigl FJ, Vitek CJ. Socioenvironmental factors and potential dengue exposure in South Texas. Appl Anthropol. 2013;33:9.
Duber HC, Kelly SM. Febrile Illness in a young traveler: Dengue fever and its complications. J Emerg Med. 2013;45:526–9.
• Lynn MK, Bossak BH, Sandifer PA, Watson A, Nolan MS. Contemporary autochthonous human Chagas disease in the USA. Acta Trop. 2020;205: 105361. This review identified 76 cases of contemporary suspected or confirmed locally acquired Chagas disease in the US, a significant increase from prior decades.
Garcia MN, Aguilar D, Gorchakov R, Rossmann SN, Montgomery SP, Rivera H, et al. Evidence of autochthonous Chagas disease in southeastern Texas. Am J Trop Med Hyg. 2015;92:325–30.
Harris N, Woc-Colburn L, Gunter SM, Gorchakov R, Murray KO, Rossmann S, et al. Autochthonous Chagas disease in the southern United States: A case report of suspected residential and military exposures. Zoonoses Public Health. 2017;64:491–3.
• Ayres J, Marcus R, Standley CJ. The importance of screening for Chagas disease against the backdrop of changing epidemiology in the USA. Curr Trop Med Rep. 2022;9:185–93. This review exemplifies the value of learning from more experienced countries how to screen for and mitigate the impact of neglected diseases, in this case, Chagas disease.
Angheben A, Boix L, Buonfrate D, Gobbi F, Bisoffi Z, Pupella S, et al. Chagas disease and transfusion medicine: A perspective from non-endemic countries. Blood Transfus. 2015;13:540–50.
Nunes MCP, Dones W, Morillo CA, Encina JJ, Ribeiro AL, Council on Chagas Disease of the Interamerican Society of Cardiology. Chagas disease: An overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013;62:767–76.
• Mills RM. Chagas disease: Epidemiology and barriers to treatment. Am J Med. 2020;133:1262–5. This review highlights the critical barriers faced by immigrants to the US with Chagas disease, including problems with financing and payment for care; limited efficacy of screening, diagnostics, and available treatment; and lack of clinical awareness, public health education, and research.
Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ. Estimating the burden of Chagas disease in the United States. PLoS Negl Trop Dis. 2016;10: e0005033.
Garcia MN, Woc-Colburn L, Aguilar D, Hotez PJ, Murray KO. Historical perspectives on the epidemiology of human Chagas disease in Texas and recommendations for enhanced understanding of clinical Chagas disease in the Southern United States. PLoS Negl Trop Dis. 2015;9: e0003981.
Tenney TD, Curtis-Robles R, Snowden KF, Hamer SA. Shelter dogs as sentinels for Trypanosoma cruzi transmission across Texas. Emerg Infect Dis. 2014;20:1323–6.
Emery D, Denning DW. The global distribution of actinomycetoma and eumycetoma. PLoS Negl Trop Dis. 2020;14: e0008397.
van de Sande W, Fahal A, Ahmed SA, Alberto Serrano J, Bonifaz A, Zijlstra E. Closing the mycetoma knowledge gap. Med Mycol. 2018;56:S153–64.
Duggal SD, Das CT. Nocardiosis: A neglected disease. Med Princ Pract. 2020;29:514–23.
Hamdi AM, Fida M, Deml SM, Abu Saleh OM, Wengenack NL. Retrospective analysis of antimicrobial susceptibility profiles of Nocardia species from a tertiary hospital and reference laboratory, 2011 to 2017. Antimicrob Agents Chemother. 2020;64:e01868-e1919.
Santos DWCL, de Azevedo CMPES, Vicente VA, Queiroz-Telles F, Rodrigues AM, de Hoog GS, et al. The global burden of chromoblastomycosis. PLoS Negl Trop Dis [Internet]. 2021;15. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85114113392&doi=10.1371%2fjournal.pntd.0009611&partnerID=40&md5=3e69ef45da9dbb4e59064c6b61d10868
Queiroz-Telles F, de Hoog S, Santos DWCL, Salgado CG, Vicente VA, Bonifaz A, et al. Chromoblastomycosis. Clin Microbiol Rev. 2017;30:233–76.
Jesudoss Chelladurai J, Murphy K, Snobl T, Bader C, West C, Thompson K, et al. Molecular epidemiology of Ascaris infection among pigs in Iowa. J Infect Dis. 2017;215:131–8.
Board AR, Suzuki S. The interrelation between intestinal parasites and latent TB infections among newly resettled refugees in Texas. Int Health. 2016;8:67–72.
Croker C, Reporter R, Redelings M, Mascola L. Strongyloidiasis-related deaths in the United States, 1991–2006. Am J Trop Med Hyg. 2010;83:422–6.
• Herrick JA, Nordstrom M, Maloney P, Rodriguez M, Naceanceno K, Gallo G, et al. Parasitic infections represent a significant health threat among recent immigrants in Chicago. Parasitol Res. 2020;119:1139–48. This study highlights the relative frequency with which immigrant populations require screening and treatment for parasitic infections, and the dual vulnerability they may face following their arrival to the US: immigrants from endemic areas are at increased risk of acquiring parasitic infection from their country of origin but also following emigration to the US if they settle in underserved areas that have an increased prevalence of parasitic infections.
Kaplan J, Centeno FH, Hayon J, Bottazzi ME, Hotez PJ, Weatherhead JE, et al. Reviewing a decade of outpatient tropical medicine in Houston. Texas Am J Trop Med Hyg. 2022;106:1049–56.
Strongyloidiasis 2023 case definition | CDC [Internet]. 2023 [cited 2023 Jun 11]. Available from: https://ndc.services.cdc.gov/case-definitions/strongyloidiasis/
Lucio-Forster A, MizhquiriBarbecho JS, Mohammed HO, Kornreich BG, Bowman DD. Comparison of the prevalence of Toxocara egg shedding by pet cats and dogs in the U.S.A., 201–201. Vet Parasitol Reg Stud Rep. 2016;5:1–13.
•• Tyungu DL, McCormick D, Lau CL, Chang M, Murphy JR, Hotez PJ, et al. Toxocara species environmental contamination of public spaces in New York City. PLoS Negl Trop Dis. 2020;14: e0008249. This study suggests that playgrounds for children throughout New York City are contaminated with Toxocara eggs and demonstrates the disparity in risk of toxocariasis for children in poorer neighborhoods.
Erickson LD, Gale SD, Berrett A, Brown BL, Hedges DW. Association between toxocariasis and cognitive function in young to middle-aged adults. Folia Parasitol (Praha). 2015;2015(62):048.
Overgaauw PAM, van Knapen F. Veterinary and public health aspects of Toxocara spp. Vet Parasitol. 2013;193:398–403.
Holland CV. Knowledge gaps in the epidemiology of Toxocara: The enigma remains. Parasitology. 2017;144:81–94.
O’Keefe KA, Eberhard ML, Shafir SC, Wilkins P, Ash LR, Sorvillo FJ. Cysticercosis-related hospitalizations in the United States, 1998–2011. Am J Trop Med Hyg. 2015;92:354–9.
O’Neal SE, Flecker RH. Hospitalization frequency and charges for neurocysticercosis, United States, 2003–2012. Emerg Infect Dis. 2015;21:969–76.
Jenkins-Holick DS, Kaul TL. Schistosomiasis. Urol Nurs. 2013;33:163–70.
Ikedionwu CA, Dongarwar D, Williams C, Odeh E, Peh MPN, Hooker H, et al. Trends and risk factors for leishmaniasis among reproductive aged women in the United States. Int J MCH AIDS. 2021;10:166–73.
Barry MA, Weatherhead JE, Hotez PJ, Woc-Colburn L. Childhood parasitic infections endemic to the United States. Pediatr Clin North Am. 2013;60:471–85.
Clarke CF, Bradley KK, Wright JH, Glowicz J. Case report: Emergence of autochthonous cutaneous leishmaniasis in northeastern Texas and southeastern Oklahoma. Am J Trop Med Hyg. 2013;88:157–61.
Blood-Siegfried J, Zeantoe GC, Evans LJ, Bondo J, Forstner JR, Wood K. The impact of nurses on neglected tropical disease management. Public Health Nurs. 2015;32:680–701.
McIlwee BE, Weis SE, Hosler GA. Incidence of endemic human cutaneous leishmaniasis in the United States. JAMA Dermatol. 2018;154:1032–9.
Kissinger P, Adamski A. Trichomoniasis and HIV interactions: A review. Sex Transm Infect. 2013;89:426–33.
Patel EU, Gaydos CA, Packman ZR, Quinn TC, Tobian AAR. Prevalence and correlates of Trichomonas vaginalis infection among men and women in the United States. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;67:211–7.
•• Tompkins EL, Beltran TA, Gelner EJ, Farmer AR. Prevalence and risk factors for Trichomonas vaginalis infection among adults in the U.S., 2013–2014. PloS One. 2020;15:e0234704. This study highlights the persistent disparity and high prevalence of TV amongst US Black women and people in poverty.
Tuddenham SA, Page KR, Chaulk P, Lobe EB, Ghanem KG. Patients fifty years and older attending two sexually transmitted disease clinics in Baltimore Maryland. Int J STD AIDS. 2017;28:330–44.
Kissinger P. Trichomonas vaginalis: A review of epidemiologic, clinical and treatment issues. BMC Infect Dis. 2015;15:307.
Lewis FMT, Spicknall IH, Flagg EW, Papp JR, Kreisel KM. Incidence and prevalence of Trichomonas vaginalis infection among persons aged 15 to 59 years: United States, 2018. Sex Transm Dis. 2021;48:232–7.
Flagg EW, Meites E, Phillips C, Papp J, Torrone EA. Prevalence of Trichomonas vaginalis among civilian, noninstitutionalized male and female population aged 14 to 59 years: United States, 2013 to 2016. Sex Transm Dis. 2019;46:e93–6.
Schwebke J, Merriweather A, Massingale S, Scisney M, Hill C, Getman D. Screening for Trichomonas vaginalis in a large high-risk population: Prevalence among men and women determined by nucleic acid amplification testing. Sex Transm Dis. 2018;45:e23–4.
• Lindrose AR, Htet KZ, O’Connell S, Marsh J, Kissinger PJ. Burden of trichomoniasis among older adults in the United States: A systematic review. Sex Health. 2022;19:151–6. This review documents a high prevalence of TV in older adults, highlighting that while the prevalence of most sexually transmitted infections is highest in adolescents and young adults, the reverse is true for TV; it also points to the need for future studies to identify subgroups of the older population that may be at higher risk of infections and/or complications.
Hearn LE, Whitehead NE, Dunne EM, Latimer WW. Correlates of Trichomonas vaginalis among middle age and older adults who use drugs. Subst Use Misuse. 2015;50:1501–9.
Gaydos CA, Barnes MR, Quinn N, Jett-Goheen M, Hsieh Y-H. Trichomonas vaginalis infection in men who submit self-collected penile swabs after internet recruitment. Sex Transm Infect. 2013;89:504–8.
Daugherty M, Glynn K, Byler T. Prevalence of Trichomonas vaginalis infection among US males, 2013–2016. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019;68:460–5.
Fan C-K, Holland CV, Loxton K, Barghouth U. Cerebral toxocariasis: Silent progression to neurodegenerative disorders? Clin Microbiol Rev. 2015;28:663–86.
Lindsey NP, Prince HE, Kosoy O, Laven J, Messenger S, Staples JE, et al. Chikungunya virus infections among travelers–United States, 2010–2013. Am J Trop Med Hyg. 2015;92:82–7.
Conners EE, Vinetz JM, Weeks JR, Brouwer KC. A global systematic review of Chagas disease prevalence among migrants. Acta Trop. 2016;156:68–78.
Garcia MN, Woc-Colburn L, Rossmann SN, Townsend RL, Stramer SL, Bravo M, et al. Trypanosoma cruzi screening in Texas blood donors, 2008–2012. Epidemiol Infect. 2016;144:1010–3.
Simeone RM, Shapiro-Mendoza CK, Meaney-Delman D, Petersen EE, Galang RR, Oduyebo T, et al. Possible Zika virus infection among pregnant women - United States and Territories, May 2016. MMWR Morb Mortal Wkly Rep. 2016;65:514–9.
Meymandi SK, Forsyth CJ, Soverow J, Hernandez S, Sanchez D, Montgomery SP, et al. Prevalence of Chagas disease in the Latin American-born population of Los Angeles. Clin Infect Dis Off Publ Infect Dis Soc Am. 2017;64:1182–8.
Bennett C, Straily A, Haselow D, Weinstein S, Taffner R, Yaglom H, et al. Chagas disease surveillance activities - Seven states, 2017. MMWR Morb Mortal Wkly Rep. 2018;67:738–41.
• Stigler Granados P, Pacheco GJ, Núñez Patlán E, Betancourt J, Fulton L. Assessing the effectiveness of Chagas disease education for healthcare providers in the United States. BMC Infect Dis. 2020;20:743. This study demonstrates a clear lack of knowledge and awareness of Chagas disease by US health care providers and suggests strategies to address these gaps as a way to reduce barriers to diagnosis and treatment.
Smitherman S, Hammond T, Goldberg D, Horney J. Developing a CASPER survey to assess the prevalence of risk factors for neglected tropical diseases in Texas. Health Secur. 2017;15:238–43.
Acknowledgements
The authors would like to thank Dr. Elizabeth R. Daly and Dr. Marcelle Layton for providing constructive feedback on the manuscript.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical Approval
This article does not contain any studies with human or animal subjects performed by any of the authors.
Conflict of Interest
The authors declare no competing interests.
Disclaimer
The contents of this review are solely the responsibility of the authors and do not necessarily represent the official views of the organization(s) with which they are affiliated.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Singer, R., Radcliffe, R. A Systematic Review of Disparities in Risk for Neglected Infections of Poverty in the United States. Curr Trop Med Rep 10, 153–165 (2023). https://doi.org/10.1007/s40475-023-00298-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40475-023-00298-5